These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2899958)

  • 1. Resistance of mice to reinfection after E-aminocaproic acid treatment of primary influenza virus infection.
    Lozitsky VP; Puzis LE; Polyak RYa
    Acta Virol; 1988 Mar; 32(2):117-22. PubMed ID: 2899958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of prophylactic administration of epsilon-amino caproic acid during influenza in mice.
    Puzis LE; Lozitsky VP; Polyak RYa
    Acta Virol; 1986 Jan; 30(1):58-62. PubMed ID: 2871734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of epsilon-aminocaproic acid on the proteolysis system during experimental influenza in mice.
    Puzis LE; Lozitsky VP
    Acta Virol; 1988 Nov; 32(6):515-21. PubMed ID: 2906223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.
    Nogusa S; Gerbino J; Ritz BW
    Nutr Res; 2009 Feb; 29(2):139-43. PubMed ID: 19285605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
    Kreijtz JH; Bodewes R; van Amerongen G; Kuiken T; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2007 Jan; 25(4):612-20. PubMed ID: 17005299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
    Kris RM; Asofsky R; Evans CB; Small PA
    J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
    Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K
    J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of epsilon-aminocaproic acid on the early stages of influenza virus reproduction].
    Fedchuk AS
    Mikrobiol Zh; 1978; 40(4):474-6. PubMed ID: 723660
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
    Stevenson PG; Hawke S; Bangham CR
    J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression of early protection against influenza virus infection by cyclophosphamide and its restoration by Y-19995 [2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate].
    Tsuru S; Shinomiya N; Nomoto K
    Nat Immun Cell Growth Regul; 1991; 10(1):1-11. PubMed ID: 2057018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection.
    Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
    Eur J Immunol; 2001 May; 31(5):1523-30. PubMed ID: 11465109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses.
    Bot A; Holz A; Christen U; Wolfe T; Temann A; Flavell R; von Herrath M
    Virology; 2000 Mar; 269(1):66-77. PubMed ID: 10725199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary immune response of young and aged mice after influenza challenge.
    Bender BS; Taylor SF; Zander DS; Cottey R
    J Lab Clin Med; 1995 Aug; 126(2):169-77. PubMed ID: 7636390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
    Hovden AO; Cox RJ; Madhun A; Haaheim LR
    Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of maternal immunity in the protection of newborn ferrets against infection with a virulent influenza virus.
    Husseini RH; Sweet C; Overton H; Smith H
    Immunology; 1984 Jul; 52(3):389-94. PubMed ID: 6745992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of endogenous hypocorticism on the replication of influenza virus in the mouse lungs and the production of specific antibodies.
    Semenkov VF; Levina LV; Lavrov VF; Ageeva ON
    Acta Virol; 1990 Feb; 34(1):37-43. PubMed ID: 1975723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.